Corrigendum to "Inhibitory effect of CP-25 on intimal formation and vascular hyperplasia via suppression of GRK2/ERK1/2/EVI1 signaling" [Arch Biochem Biophys. 2020 Nov 15;694:108601]
Arch Biochem Biophys. 2022 Jan 15:715:109097.
doi: 10.1016/j.abb.2021.109097.
Epub 2021 Nov 29.
1 Department of Cardiology, Liuzhou Municipal Liutie Central Hospital, Guangxi Autonomous Region, PR China.
2 Department of Cardiology, The Second People's Hospital of Nanning City, The Third Affiliated Hospital of Guangxi Medical University, Guangxi Autonomous Region, PR China.
3 Department of Cardiology, The First Affiliated Hospital of Sun Yat-sen University, Guangdong, PR China.
4 Department of Cardiology, Affiliated Hospital of Guilin Medical University, Guangxi Autonomous Region, 541001, PR China.
5 Department of Cardiology, Affiliated Hospital of Guilin Medical University, Guangxi Autonomous Region, 541001, PR China. Electronic address: [email protected].